Home ยป “Increased Use and Costs ofMultiple Sclerosis Disease-Modifying Therapies in Australia (2013-2022) with Higher Efficacy Treatments and State Variations”

“Increased Use and Costs ofMultiple Sclerosis Disease-Modifying Therapies in Australia (2013-2022) with Higher Efficacy Treatments and State Variations”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38116594

Multiple sclerosis disease-modifying therapy use and costs significantly increased in Australia from 2013 to 2022, with a shift towards higher efficacy treatments and variations between states.

You may also like

Leave a Comment